Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa D Conrad

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Changes in susceptibility of <i>Plasmodium falciparum</i> to antimalarial drugs in Uganda over time: 2019-2024Martin Okitwi, Stephen Orena, Patrick K Tumwebaze, et al.
Plos Neglected Tropical Diseases|April 6, 2012
Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalisMelissa D Conrad, Andrew W Gorman, Julia A Schillinger, et al.
The Journal of Infectious Diseases|May 23, 2023
Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control StudyMichelle E Roh, Issaka Zongo, Alassane Haro, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2016
Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug SensitivityJoaniter I Nankabirwa, Melissa D Conrad, Jennifer Legac, et al.
The American Journal of Tropical Medicine and Hygiene|May 7, 2014
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in UgandaGeorge W Mbogo, Sheila Nankoberanyi, Stephen Tukwasibwe, et al.
Nature Communications|August 9, 2025
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024Martin Okitwi, Stephen Orena, Patrick K Tumwebaze, et al.
The Journal of Infectious Diseases|November 25, 2015
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized TrialAdoke Yeka, Ruth Kigozi, Melissa D Conrad, et al.
Malaria Journal|December 29, 2019
Impact of vector control interventions on malaria transmission intensity, outdoor vector biting rates and Anopheles mosquito species composition in Tororo, UgandaAlex K Musiime, David L Smith, Maxwell Kilama, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
A novel locus associated with decreased susceptibility of Plasmodium falciparum to lumefantrine and dihydroartemisinin has emerged and spread in UgandaKaramoko Niare, Bersabeh Tafesse, Mayland Treat, et al.
The Journal of Infectious Diseases|November 4, 2020
Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across UgandaVictor Asua, Melissa D Conrad, Ozkan Aydemir, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Changes in susceptibility of <i>Plasmodium falciparum</i> to antimalarial drugs in Uganda over time: 2019-2024Martin Okitwi, Stephen Orena, Patrick K Tumwebaze, et al.
Plos Neglected Tropical Diseases|April 6, 2012
Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalisMelissa D Conrad, Andrew W Gorman, Julia A Schillinger, et al.
The Journal of Infectious Diseases|May 23, 2023
Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control StudyMichelle E Roh, Issaka Zongo, Alassane Haro, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2016
Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug SensitivityJoaniter I Nankabirwa, Melissa D Conrad, Jennifer Legac, et al.
The American Journal of Tropical Medicine and Hygiene|May 7, 2014
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in UgandaGeorge W Mbogo, Sheila Nankoberanyi, Stephen Tukwasibwe, et al.
Nature Communications|August 9, 2025
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024Martin Okitwi, Stephen Orena, Patrick K Tumwebaze, et al.
The Journal of Infectious Diseases|November 25, 2015
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized TrialAdoke Yeka, Ruth Kigozi, Melissa D Conrad, et al.
Malaria Journal|December 29, 2019
Impact of vector control interventions on malaria transmission intensity, outdoor vector biting rates and Anopheles mosquito species composition in Tororo, UgandaAlex K Musiime, David L Smith, Maxwell Kilama, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
A novel locus associated with decreased susceptibility of Plasmodium falciparum to lumefantrine and dihydroartemisinin has emerged and spread in UgandaKaramoko Niare, Bersabeh Tafesse, Mayland Treat, et al.
The Journal of Infectious Diseases|November 4, 2020
Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across UgandaVictor Asua, Melissa D Conrad, Ozkan Aydemir, et al.
Pageof 7